Bioasis and Chiesi Group to Host Webcast on July 16, 2020

10-07-2020

Thomas Eichholtz appointed new Head of Global Research and Development at the Chiesi Group

10-07-2020

Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance

30-06-2020

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease

28-05-2020

Chiesi Group Receives FDA Approval for Ferriprox® (deferiprone) twice-a-day tablets

21-05-2020

Chiesi Global Rare Diseases Recognizes Fabry Disease Awareness Month and Launches “Fabry Focus on Health” Educational Series to Support Patients and Caregivers During COVID-19 Pandemic

24-04-2020

Chiesi USA increases support measures for employees, patients and community partners in response to COVID-19 pandemic

31-03-2020

Chiesi USA certified as a Great Place to Work® in 2019

02-03-2020

Chiesi Global Rare Diseases Recognizes Rare Disease Day and Highlights Plans to Expand Focus on Patient Advocacy in 2020

27-02-2020

Chiesi in the Community donates nearly $1 million in 2019

26-02-2020

Chiesi Group Announces Establishment of New Global Rare Diseases Division

06-02-2020

Chiesi USA, Inc. Receives Top Employer in the U.S. Certification for 2020

30-01-2020

Chiesi Group and Apotex Inc. finalize agreement for acquisition of Ferriprox® (deferiprone)

13-01-2020

Chiesi and Durham Bulls Partnership Culminates in $15,000 to Triangle Nonprofits

04-09-2019

Chiesi Group confirms positive trend to date for 2019

09-07-2019

Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

06-06-2019

Triangle Business Journal Recognizes Chiesi USA, Inc. With Third Consecutive Corporate Philanthropy Award

05-06-2019

Paolo Chiesi is Appointed Honorary Doctor at Karolinska Institutet

15-05-2019

Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run

26-04-2019

Chiesi and Durham Bulls Partnership Steps up to Bat for Local Charities

22-04-2019

Chiesi USA Promotes Medical Affairs Head to Support Continued Corporate Growth

16-04-2019

Chiesi USA, Inc. Moves to New Headquarters in Regency Woods II

26-02-2019

Chiesi Joins National Organization for Rare Disorders (NORD)® Corporate Council

21-02-2019

Chiesi USA, Inc. Receives Top Employer in the US Certification for 2019

31-01-2019

Chiesi in the Community Donates approximately $850,000 in 2018

28-01-2019

Chiesi USA Attains Public Benefit Corporation Status, Pledges to Advance Positive Community Impact

11-01-2019

Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®

14-11-2018

Chiesi Salutes Nurses Surrounding Neonatal Nurses Day 2018

18-09-2018

Chiesi Partnership with Durham Bulls Closes Season with $15,000 to Area Nonprofits

06-09-2018

Chiesi USA, Inc. Named a Best Place to Work

22-08-2018

Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals

14-08-2018

Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)

12-06-2018